Biomedical Engineering Reference
In-Depth Information
Kurath, M., Maasen, S. 2006. Toxicology as a nanoscience?—Disciplinary identities reconsidered. Part Fibre
Toxicol 3(6) doi: 10.1186/1743-8977-3-6.
Lam, C.W., James, J.T., McCluskey, R., Hunter, R.L. 2004. Pulmonary toxicity of single-wall carbon nanotubes
in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126-134.
Langer, R. 2002. Biomaterials in drug delivery and tissue engineering: One laboratory's experience. Acc Chem
Res 33:94-101.
Lanone, S., Boczkowski, J. 2006. Biomedical applications and potential health risks of nanomaterials:
Molecular mechanisms. Curr Mol Med 6(6):651-663.
Lee, M., Kim, S.W. 2005. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res
22:1-10.
Lewinski, N., Colvin, V., Drezek, R. 2008. Cytotoxicity of nanoparticles. Small 4:26-49. doi:10.1002/smll.2007
00595.
Lin, W., Huang, Y.W., Zhou, X.D. et al. 2006. In vitro toxicity of silica nanoparticles in human lung cancer
cells. Toxicol Appl Pharmacol 217:252-259.
Lippmann, M. 1990. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health
Perspec 88:311-317.
Loeschner, K., Hadrup, N. et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure
to silver nanoparticles or silver acetate. Particle Fiber Technol 8. doi: 10.1186/1743-8977-8-18.
Lovric, J., Cho, S.J., Winnik, F.M. et  al. 2005. Unmodified cadmium teluride quantum dots induce reac-
tive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol
12:1159-1161.
Matsudai, M., Hunt, G. 2005. Nanotechnology and public health. Nippon Koshu Eisei Zasshi 52:923-927.
Maynard, A.D., Aitken, R.J., Butz, T. et al. 2006. Safe handling of nanotechnology. Nature 444:267-269. doi:
10.1038/444267a
Medina, C., Santos-Martinez, M.J., Radomski, A., Corrigan, O.I., Radomski, M.W. 2007. Nanoparticles:
Pharmacological and toxicological significance. Br J Pharmacol 150(5):552-558.
Moghimi, S.M., Hunter, A.C., Murray, J.C. 2005. Nanomedicine: Current status and future prospects. FASEB
J 19:311-330.
Mohanraj, V.J., Chen, Y. 2006. Nanoparticles—A review. Trop J Pharm Res 5(1):561-573.
Monteiro-Riviere, N.A., Nemanich, R.J., Inman, A.O., Wang, Y.Y., Riviere, J. E. 2005. Multi-walled carbon
nanotube interactions with human epidermal keratinocytes. Toxicol Lett 155:377-384.
Muller, J., Huaux, F., Moreau, N., Misson, P., Heiliea, J.F., Delos, M., Arras, M., Fonseca, A., Nagyb, J.B., Lison,
D. 2005. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207:221-231.
Nahar, M., Dutta, T., Murugesan, S. et al. 2006. Functional polymeric nanoparticles: An efficient and promising
tool for active delivery of bioactives. Crit Rev Ther Drug Carrier Syst 23(4):259-318.
Nel, A., Xia, T., Madler, L., Li, N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
doi: 10.1126/science.1114397.
Niidome, T., Yamagata, M., Okamoto, Y. et al. 2006. PEG-modified gold nanorods with a stealth character for
in vivo applications. J Control Release 114:343-347.
Oberdörster, G. 2002. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhalation Toxicol
14:29-56.
Oberdörster, G., Ferin, J., Lehnert, B.E. 1994. Correlation between particle size, in vivo particle persistence,
and lung injury. Environ Health Perspect 102(5):173-179.
Oberdörster, G., Oberdorster, E., Oberdorster, J. 2005. Nanotoxicology: An emerging discipline evolving from
studies of ultrafine particles. Environ Health Perspect 113(7):823-839.
Oberdörster, G., Sharp, Z., Atudorei, V. et  al. 2004. Translocation of inhaled ultrafine particles to the brain.
Inhal Toxicol 16:437-445. doi: 10.1080/08958370490439597.
Osaka, T., Nakanishi, T., Shanmugam, S., Takahama, S., Zhang, H. 2009. Effect of surface charge of magnetite
nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids
Surf B: Biointerfaces 71:325-330.
Pan, Y., Leifert, A., Ruau, D. et al. 2009. Gold nanoparticles of diameter 1.4 mm trigger necrosis by oxidative
stress and mitochondrial damage. Small 5(18):2067-2076.
Panyam, J., Labhasetwar, V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
Adv. Drug Delivery Rev 55:329-347.
Panyam, J., Sahoo, S.K., Prabha, S., Bargar, T., Labhasetwar, V., 2003b. Fluorescence and electron microscopy
probes for cellular and tissue uptake of poly(D,L-lactide-coglycolide) nanoparticles. Int J Pharm 262, 1-11.
Parveen, S., Misra, R., Sahoo, S.K. 2012. Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and
imaging. Nanomedicine: NBM 8:147-166. doi: 10.1016/j.nano.2011.05.016.
Search WWH ::




Custom Search